Clinical trial
Vinorelbine, Gemcitabine, and Docetaxel Compared With Paclitaxel and Carboplatin…
NCT00079287 · Japan Multinational Trial Organization, Other · Completed
Key facts
| NCT number | NCT00079287 |
|---|---|
| Title | Vinorelbine, Gemcitabine, and Docetaxel Compared With Paclitaxel and Carboplatin in Treating Patients With Advanced Non-Small Cell Lung Cancer |
| Official title | Phase III Randomized Comparison Study of Vinorelbine, Gemcitabine, and Docetaxel Versus Paclitaxel and Carboplatin in Patients With Advanced Non-Small Cell Lung Cancer |
| Lead sponsor | Japan Multinational Trial Organization, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug |
| Interventions | carboplatin, docetaxel, gemcitabine hydrochloride, paclitaxel, vinorelbine tartrate |
| Start date | Mar 1, 2001 |
| Completion | Nov 1, 2008 |
| First posted | Mar 10, 2004 |
| Last update posted | Sep 17, 2013 |
| Countries | Japan |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: